| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |